Real Time Genomics

Executive Summary

Real Time Genomics (RTG) is a New Zealand-based software company specializing in the rapid and accurate analysis of DNA sequencing data for clinical and research applications. Founded in 2009, the company has developed a platform that enables real-time genomic data interpretation, reducing turnaround times for diagnostic results. RTG's technology is critical in precision medicine, where timely genomic insights can guide treatment decisions, particularly in oncology and rare diseases. The company's software integrates with existing sequencing workflows, offering scalability and ease of use for laboratories. With a strong focus on accuracy and speed, RTG addresses the growing demand for actionable genomic data in healthcare. While the company operates in a competitive landscape dominated by larger players, its niche in real-time analysis and its presence in the Asia-Pacific region provide a unique value proposition. The company is privately held and has not disclosed funding rounds, but its sustained operations since 2009 indicate a viable business model. As genomic sequencing becomes more widespread, RTG is well-positioned to capitalize on the need for efficient data analysis solutions.

Upcoming Catalysts (preview)

• Q3 2026Partnership with Major Hospital Network for Clinical Deployment70% success
• Q4 2026Launch of Cloud-Based Real-Time Analysis Platform65% success
• Q1 2027Regulatory Clearance in Key Market (e.g., FDA or CE Mark)50% success